LONDON (Reuters) - Multi-drug resistant strains of tuberculosis (TB) could become dominant forms of the disease in the next few decades, adding heavy financial and medical burdens to already ...

LONDON Experts gathered in London last week to call for urgent action to tackle the global problem of multi-drug resistant tuberculosis. Resistance to the commonly used anti-TB drugs is increasing ...

The World Health Organization’s guidelines for treating multidrug-resistant tuberculosis include the use of at least five potentially effective drugs. However, a new PLOS Medicine prospective cohort ...

More than 10 million people fall sick with tuberculosis (TB) every year. The disease remains the world’s biggest infectious disease killers with an estimated 1.25 million annual deaths. The disease is ...

An international research team headed by scientists at the University of British Columbia has demonstrated how a novel semi-synthetic compound derived from sanguinarine (SG), an alkaloid extracted ...

For patients with multidrug-resistant tuberculosis (TB), taking at least six potentially effective drugs, particularly including pyrazinamide, significantly increased the likelihood of achieving a ...

The number of cases of multidrug-resistant tuberculosis is increasing in the United States, as is the fraction of those cases that is resistant to at least five antimicrobial drugs. The Centers for ...

The World Health Organization (WHO) warns of a “ticking time bomb” as tuberculosis is getting increasingly resistant to antibiotics. According to the WHO, almost 500,000 people have a type of TB that ...

A modified compound taken from bloodroot, a wildflower native to North America, effectively fights multidrug-resistant tuberculosis (TB) bacteria in the test tube, according to a new study. The ...

WASHINGTON (Reuters) - A new combination of three drugs killed 99 percent of patients' tuberculosis bacteria in two weeks, raising hope for a new weapon against increasingly resistant forms of TB. The ...